Clinical Trial Update: Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating strategies to minimize adverse haemorrhagic events using transradial access and angioX in acute coronary syndromes an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Non-st-elevation Myocardial Infarction
• St-elevation Myocardial Infarction

Drugs mentioned

• Angiox (bivalirudin)

Snippet

Sponsor: Italian Society of Invasive Cardiology | Conditions: Acute Coronary Syndromes, STEMI | Phase 3 | Status: UNKNOWN